LabCorp (United States)
In research, LabCorp (United States) stands highest in Medicine (#4,437 of 10,443 worldwide), Health Sciences (#5,424 of 11,982 worldwide) and Life Sciences (#3,644 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 5.9× its share of world research.
- World rank, 2022–2025
- #6,768 of 28,054 · #8,209 all time
- Rank in United States
- #903 of 4,192
- Research works
- 1.2k ▲ 84% vs 2013–17
- Citations
- 29k 24.0 per fractional work
- Top-10% rate
- 11.7% record average 16.5%
- Open access
- 46% world 28%
What is LabCorp (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,437 of 10,443 | 11.2% | 204 | #5462 | |
| Health SciencesDomain | #5,424 of 11,982 | 11.0% | 219 | #6681 | |
| Life SciencesDomain | #3,644 of 7,800 | 9.5% | 123 | #3557 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,358 of 3,579 | 7.6% | 80 | #4163 |
Each strip is that field’s whole ranked pool, with the notch where LabCorp (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#5,462 #4,437
- Health Sciences#6,681 #5,424
- Life Sciences#3,557 #3,644
- Biochemistry, Genetics and Molecular Biology#4,163 #3,358
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does LabCorp (United States) specialise in?
Where its research is concentrated relative to its size: Oncology takes 5.9× the share of its output that it takes of world research.
- OncologySubfield · 29.1 works5.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 9.1×. Every wedge is a field page.
- Veterinary 9.1×
- Immunology and Microbiology 5.1×
- Biochemistry, Genetics and Molecular Biology 3.4×
- Medicine 2.4×
- Pharmacology, Toxicology and Pharmaceutics 1.6×
- Economics, Econometrics and Finance 1.1×
- Neuroscience 1.0×
- Nursing 1.0×
- Chemical Engineering 0.8×
- Chemistry 0.7×
- Mathematics 0.7×
- Decision Sciences 0.6×
- Health Professions 0.6×
- Agricultural and Biological Sciences 0.5×
- Environmental Science 0.4×
- Computer Science 0.4×
- Engineering 0.4×
- Psychology 0.4×
- Business, Management and Accounting 0.3×
- Arts and Humanities 0.2×
- Social Sciences 0.2×
- Energy 0.2×
- Materials Science 0.1×
- Earth and Planetary Sciences 0.1×
- Dentistry 0.0×
Who are the top researchers at LabCorp (United States)?
Ranked on the composite score, James D. Otvos, Christos J. Petropoulos and M. Hollings lead among researchers whose main affiliation is LabCorp (United States).
- 1 James D. Otvos United States · #160,473 worldwide 238 citations · 52 works
- 2 Christos J. Petropoulos United States · #226,218 worldwide 181 citations · 33 works
- 3 M. Hollings United States · #257,781 worldwide 124 citations · 22 works
- 4 Taylor J. Jensen United States · #361,416 worldwide 78 citations · 23 works
- 5 Margery A. Connelly United States · #402,974 worldwide 117 citations · 43 works
- 6 Alok Sharma United States · #1,033,197 worldwide 53 citations · 20 works
- 7 Scott Wise United States · #1,242,454 worldwide 26 citations · 19 works
- 8 Kelly Chun United States · #1,287,718 worldwide 16 citations · 16 works
- 9 Marcia Eisenberg United States · #1,547,371 worldwide 8 citations · 15 works
Which keywords describe research at LabCorp (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Epidemiology, Targeted Therapy, Cell-Free DNA, Inflammation, Metabolic Syndrome, Genomic Instability and Tumor Microenvironment.
- Therapeutic Antibodies
- Antibody Engineering
- Prenatal Diagnosis
- Mass Spectrometry
- Gene Therapy
- Genetic Testing
- Prognostic Factors
- Data Analysis
- Immune Checkpoint Blockade
- Tumor Regression
- Monoclonal Antibodies
- Chemotherapy
- Biomarkers
- Cancer Genomics
- Oxidative Stress
- Clinical Trials
- Tumor Microenvironment
- Metabolic Syndrome
- Targeted Therapy
- Inflammation
- Epidemiology
- Immunotherapy
- Cell-Free DNA
- Machine Learning
- Cancer
- Cardiovascular Disease
- Genomic Instability
- Mutational Signatures
- Gene Expression
- Precision Medicine
- Immunity
- Cancer Immunotherapy
- PD-1 and PD-L1
- Insulin Resistance
- SARS-CoV-2
- Cardiovascular Risk
- Glycosylation
- Lymphoma
- Tumor Targeting
- Fc Receptors
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology35▲ 2.0×83 topics
- Inflammation23▲ 2.6×60 topics
- Immunotherapy20▲ 6.4×16 topics
- Targeted Therapy17▲ 18×4 topics
- Cell-Free DNA16▲ 38×2 topics
- Metabolic Syndrome16▲ 4.4×18 topics
- Machine Learning15◆ 1.08×24 topics
- Tumor Microenvironment12▲ 6.5×7 topics
- Cancer12▲ 2.1×32 topics
- Clinical Trials12▲ 4.2×11 topics
- Cardiovascular Disease12▲ 2.5×23 topics
- Oxidative Stress12▲ 1.67×37 topics
- Genomic Instability12▲ 24×2 topics
- Cancer Genomics11▲ 36×1 topic
- Mutational Signatures11▲ 36×1 topic
- Biomarkers11▲ 3.8×15 topics
- Gene Expression11▲ 4.1×11 topics
- Chemotherapy10▲ 3.4×18 topics
- Precision Medicine10▲ 4.9×7 topics
- Monoclonal Antibodies10▲ 24×3 topics
- Immunity9▲ 4.9×8 topics
- Tumor Regression8▲ 18×2 topics
- Cancer Immunotherapy8▲ 12×3 topics
- Immune Checkpoint Blockade8▲ 17×1 topic
- PD-1 and PD-L18▲ 17×1 topic
- Data Analysis8▲ 6.8×4 topics
- Insulin Resistance8▲ 4.0×8 topics
- Prognostic Factors8▲ 4.0×8 topics
- SARS-CoV-27▲ 5.0×6 topics
- Genetic Testing7▲ 14×3 topics
- Cardiovascular Risk7▲ 5.1×8 topics
- Gene Therapy7▲ 8.3×5 topics
- Glycosylation7▲ 14×3 topics
- Mass Spectrometry7▲ 10×4 topics
- Lymphoma6▲ 9.3×3 topics
- Prenatal Diagnosis6▲ 9.4×5 topics
- Tumor Targeting6▲ 7.8×3 topics
- Antibody Engineering5▲ 22×1 topic
- Fc Receptors5▲ 22×1 topic
- Therapeutic Antibodies5▲ 17×2 topics
Which research topics does LabCorp (United States) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Monoclonal and Polyclonal Antibodies Research and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 11 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 5 works
- 4 CAR-T cell therapy research Oncology 5 works
- 5 Prenatal Screening and Diagnostics Pediatrics, Perinatology and Child Health 5 works
- 6 Animal testing and alternatives Small Animals 4 works
- 7 Biosimilars and Bioanalytical Methods Immunology 4 works
- 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 9 Immunodeficiency and Autoimmune Disorders Immunology 4 works
- 10 Cancer Research and Treatments Biotechnology 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has LabCorp (United States)'s research output changed?
Output in 2018–2022 was 84% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.